Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SURP and G patch domain containing 1 pseudogene (ENSG00000258320, LOC100128674) is classified as a pseudogene in the human genome[5]. Pseudogenes are DNA sequences resembling genes but are typically non-functional, lacking the ability to encode functional proteins due to mutations or obsolescence. There is no evidence that this locus encodes a protein or participates in biological processes, nor is it implicated as a receptor, enzyme, transporter, or any kind of drug target[5]. Its designation as a pseudogene means it is not considered a therapeutic target and it is not associated with disease mechanisms, drug interactions, or biomarker applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SURP and G patch domain containing 1 pseudogene.